Abstract-A fish full life-cycle (FFLC) study was conducted for 17 using the fathead minnow, Pirnephales promelas. Newly fertilized embryos «24 h old) were exposed to fi ve concentrations of EEl (0.2, 1.0, 4.0, 16, and 64 ng/L nominal) in continuous flow-through conditions for 305 d at 25 ::' : 1°C. Exposure concentrations were verified by 14e-EE2 radiochemistry, supported by radioimmunoassay, and mean measured values were~70% of nominal. For the F o adult phase until 301 d posthatch, the no-observed-effect concentrations (NOEes) for growth, survival, and reproduction (as egg production) were all~1.0 ng/L. The NOEC values for F 1 embryo hatching success and larval sll1'vival (at 28 d posthatch) were both~LO ng/L. While statistically detectable changes in F 1 growth were evident at 0.2 nglL, these were not considered to be biologically significant when compared with historical control data. Male fish exposed to EE z at 4.0 ng/L failed to develop normal secondary sexual characteristics; on the other haud, assumed females exposed to this level of EE z were able to breed when paired with males that had not been exposed to EE,. Histology of F o control, 0.2-, and l-ng/L exposed fish at 56 d posthatch indicated an approximate female-to-male (F:M) sex ratio of 50:50 (with no ovatestes observed in the control), while fish exposed to EE z at 4.0 ng/L for 56 d posthatch had a F: M sex ratio of 84:5 (with ovatestes in 11% of fish). After 172 d posthatch, no testicular tissue was observed in any fish exposed to EE z at 4.0 ng/L. At the same time point, plasma vitellogenin levels were significantly higher in fish exposed to EE z at 16 ngl 1. A lack of sexual differentiation oceurred in males at concentrations~4.0 ng/L. Taking into account these data, the overall noobserved-adverse-effect concentration was considered to be 1.0 ng/L.
A fish full life-cycle (FFLC) study was conducted for 17 alpha-ethinylestradiol (EE2) using the fathead minnow, Pimephales promelas. Newly fertilized embryos (< 24 h old) were exposed to five concentrations of EE2 (0.2, 1.0, 4.0, 16, and 64 ng/L nominal) in continuous flow-through conditions for 305 d at 25 +/- 1 degrees C. Exposure concentrations were verified by 14C-EE2 radiochemistry, supported by radioimmunoassay, and mean measured values were > or = 70% of nominal. For the F0 adult phase until 301 d posthatch, the no-observed-effect concentrations (NOECs) for growth, survival, and reproduction (as egg production) were all > or = 1.0 ng/L. The NOEC values for F1 embryo hatching success and larval survival (at 28 d posthatch) were both > or = 1.0 ng/L. While statistically detectable changes in F1 growth were evident at 0.2 ng/L, these were not considered to be biologically significant when compared with historical control data. Male fish exposed to EE2 at 4.0 ng/L failed to develop normal secondary sexual characteristics; on the other hand, assumed females exposed to this level of EE2 were able to breed when paired with males that had not been exposed to EE2. Histology of F0 control, 0.2-, and 1-ng/L exposed fish at 56 d posthatch indicated an approximate female-to-male (F:M) sex ratio of 50:50 (with no ovatestes observed in the control), while fish exposed to EE2 at 4.0 ng/L for 56 d posthatch had a F:M sex ratio of 84:5 (with ovatestes in 11% of fish). After 172 d posthatch, no testicular tissue was observed in any fish exposed to EE2 at 4.0 ng/L. At the same time point, plasma vitellogenin levels were significantly higher in fish exposed to EE2 at 16 ng/L. A lack of sexual differentiation occurred in males at concentrations > or = 4.0 ng/L. Taking into account these data, the overall no-observed-adverse-effect concentration was considered to be 1.0 ng/L.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.